type 2 diabetes mellitus
Conditions
Interventions
Control group::Patients in the control group were treated with conventional multiple subcutaneous insulin injections. NovoRapid was injected subcutaneously before meals, and glucagon insulin (Lantus)
Treatment group:Patients in the treatment group were given a patch insulin pump from MicroTech Medical. The treatment regimen consisted of the basic dosage of continuous short-acting insulin (NovoRapi
Sponsors
Lanzhou First People's Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Conform to the diagnostic and typing standards for diabetes formulated by WHO in 1999; (2) Age range from 40 to 65 years old; (3) HbA1C = 9.0% or FPG = 11.1;
Exclusion criteria
Exclusion criteria: Type 1 diabetes, diabetes ketoacidosis. Excluding heart, liver, and pancreatic diseases, excluding infections, tumors, immune diseases, urinary tract infections, severe hypertension, and heart failure. No acute complications and serious chronic complications of diabetes have occurred recently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TNF-a ;NF-?B ;CD14;FOXO1;Monocyte MFI values; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol;triglyceride;Low density lipoprotein;High density lipoprotein;mean amplitude of glycemic excursions;Total length of hospital stay; | — |
Countries
China
Contacts
Public ContactCai-ling HE
Lanzhou First People's Hospital
Outcome results
None listed